supplementary material – Page 4 – Communicable Diseases Research

Was Alpha deadlier than wild-type COVID? Analysis in rural England

Original Paper

Published on 2022-03-052022-10-29
Journal: Infection [Category] COVID-19, COVID19(2023년), MERS, SARS, 변종,

Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study

Research

Published on 2022-03-052022-10-27
Journal: BMC Geriatrics [Category] COVID-19,

Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study

Research

Published on 2022-03-052022-10-27
Journal: BMC Geriatrics [Category] Coronavirus, COVID-19, MERS, SARS,

The HIV Cascade of Care and Service Utilisation at Sex Work Programmes Among Female Sex Workers in South Africa

남아프리카의 여성 성 노동자들 사이에서 성 노동 프로그램에서의 HIV 캐스케이드 간호 및 서비스 활용

Original Paper

Published on 2022-03-052022-09-10
Journal: AIDS and Behavior [Category] MERS, 치료제,

Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients

Research

Published on 2022-03-052022-10-28
Journal: Annals of Intensive Care [Category] COVID-19,

[키워드] administration Admission alteration alterations approaches Bacterial sepsis Blood Cell cell proliferation characteristic clinical setting collected COVID-19 COVID-19 patient COVID-19 patients Critically ill Critically ill patient CTLA-4 described evaluated Ex vivo Exhaustion expression feature flow cytometry hallmark Hospitalized ICU ICU admission ICU patient IFN-γ immune immunostimulation inhibited intensive care interleukin-7 lymphopenic marker mononuclear cell over-expression pathophysiology Pathways Patient PD-L1 peripheral proliferation recombinant Result reversed SARS-CoV-2 Sepsis severe coronavirus disease severe COVID-19 severe COVID-19 patient significantly supplementary material T cell T cell activation T cell proliferation T lymphocyte T lymphocyte response T lymphocytes therapeutic therapeutic strategy therapy transcriptomic profile treat
[DOI] 10.1186/s13613-022-00982-1 PMC 바로가기 [Article Type] Research

Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19

Research

Published on 2022-03-052022-10-30
Journal: Immunity & Ageing : I & A [Category] COVID-19,

[키워드] “cytokine storm” affected age Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody assessment baseline Biomarker Cohort Comorbidities conducted COVID-19 COVID-19 patient COVID-19 severity cytokine Cytokine dynamics early response elevated enrolled Hospital admission Hospitalization hospitalized patient Human immune system IgG IgG titer IgG/IgM antibodies IgM IL-10 IL-6 IL-8 ill patients immune responses Inflammatory cytokine laboratory-confirmed older patient older patients Patient Peripheral blood positively correlated response Result Retrospective study risk factor SARS-CoV-2 serum cytokine severely ill patient severely ill patients Significant significantly higher supplementary material survival symptom onset titers of IgG TNF-α with COVID-19
[DOI] 10.1186/s12979-022-00271-2 PMC 바로가기 [Article Type] Research

Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B 2 receptor antagonism

키닌 B 2 수용체 길항작용에 의한 기관지 상피의 SARS-CoV-2 복제의 조기 감소

Original Article

Published on 2022-03-052022-09-10
Journal: Journal of Molecular Medicine (Berlin, Germany) [Category] COVID19(2023년), SARS, 유전자 메커니즘,

[키워드] ACE2 ACE2 receptor airway airway epithelial cell airway epithelial cells Airway inflammation Analysis analyzed antagonism antagonist antagonists approved assays B₂R-antagonist Bronchial epithelium cellular clinical study complex controls COVID-19 Critical cytotoxicity early-stage COVID-19 entry receptor epithelial epithelial cells Evidence Ex vivo expression of SARS-CoV-2 Future G protein Host Icatibant immune regulation in vitro in vivo in vivo model induction Infection information inhibiting inhibiting viral replication Interference Kallikrein Kinin Kinin-kallikrein-system mechanism murine nasal nasal mucosa negative nose pathway performed Plaque assay plaque assays PROTECT protection provide receptor receptor signaling reduce reduced reduction Replication RT-qPCR SARS-CoV-2 SARS-CoV-2 entry receptor SARS-CoV-2 replication SARS-CoV-2 RNA SARS-CoV-2-positive patients Signaling Spread study participant Study participants supplementary material symptomatic Transcriptome transcriptomes translational Transport treated Treatment upregulation Vero-E6 cells Viral viral replication were infected
[DOI] 10.1007/s00109-022-02182-7 PMC 바로가기 [Article Type] Original Article

Concerns among people who use opioids during the COVID-19 pandemic: a natural language processing analysis of social media posts

Observational Study

Published on 2022-03-052022-10-04
Journal: Substance Abuse Treatment, Prevention, and Policy [Category] MERS, SARS, 임상,

Knowledge, attitude and perception of West Africans towards COVID-19: a survey to inform public health intervention

Research

Published on 2022-03-052022-10-28
Journal: BMC Public Health [Category] COVID-19, MERS, SARS,

[키워드] African average conducted coronavirus 2 country COVID-19 COVID-19 knowledge score COVID-19 patient COVID-19 symptoms COVID-19 vaccine curtail develop Epidemics Government Health Healthcare professional identify IMPROVE infected with SARS-CoV-2 Isolation knowledge Knowledge, attitude and perception measure MOST National Nigeria Novel coronavirus pandemic Pandemics participant participated Perception positive attitude preventative measure preventive measure Public health intervention question receive respiratory Result SARS-CoV-2 significantly sociodemographic data Spread supplementary material the disease Transmission Treatment Vaccine acceptance was performed West West Africa
[DOI] 10.1186/s12889-022-12814-9 PMC 바로가기 [Article Type] Research

COVAX, vaccine donations and the politics of global vaccine inequity

Research

Published on 2022-03-052022-11-01
Journal: Globalization and Health [Category] COVID-19, MERS, SARS,